Croda International Plc (LON:CRDA - Get Free Report) insider Steve Foots bought 5 shares of the company's stock in a transaction dated Monday, May 11th. The stock was purchased at an average price of GBX 2,850 per share, for a total transaction of £142.50.

Steve Foots also recently made the following trade(s):

• On Tuesday, May 5th, Steve Foots sold 73 shares of Croda International stock. The stock was sold at an average price of GBX 2,840, for a total transaction of £2,073.20.
• On Friday, April 10th, Steve Foots bought 5 shares of Croda International stock. The stock was purchased at an average price of GBX 2,950 per share, for a total transaction of £147.50.
• On Tuesday, March 17th, Steve Foots sold 3,622 shares of Croda International stock. The stock was sold at an average price of GBX 2,606, for a total transaction of £94,389.32.
• On Tuesday, March 10th, Steve Foots bought 6 shares of Croda International stock. The stock was purchased at an average price of GBX 2,798 per share, for a total transaction of £167.88.

Croda International Trading Down 1.1%

Shares of LON CRDA opened at GBX 2,790 on Wednesday. The firm's 50 day moving average price is GBX 2,843.96 and its 200-day moving average price is GBX 2,822.81. The company has a market cap of £3.89 billion, a PE ratio of 62.84, a P/E/G ratio of 1.40 and a beta of 0.90. Croda International Plc has a 52-week low of GBX 2,426.77 and a 52-week high of GBX 3,312. The company has a debt-to-equity ratio of 31.85, a quick ratio of 2.25 and a current ratio of 1.99.

---

---

Croda International (LON:CRDA - Get Free Report) last issued its earnings results on Tuesday, February 24th. The company reported GBX 146.20 earnings per share (EPS) for the quarter. Croda International had a net margin of 3.65% and a return on equity of 2.82%. On average, equities research analysts expect that Croda International Plc will post 181.8307268 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Croda International from GBX 3,100 to GBX 3,000 and set a "hold" rating for the company in a report on Tuesday, March 24th. Jefferies Financial Group reissued a "hold" rating and set a GBX 3,000 price objective on shares of Croda International in a report on Wednesday, April 22nd. Finally, Morgan Stanley raised shares of Croda International to an "overweight" rating and boosted their price objective for the company from GBX 3,280 to GBX 3,350 in a report on Wednesday, March 25th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Croda International currently has a consensus rating of "Moderate Buy" and an average target price of GBX 3,140.

Get Our Latest Stock Analysis on CRDA

Croda International Company Profile

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

Further Reading

• Five stocks we like better than Croda International
• Navy Catalyst Ignites Odysight’s Growth Engine
• AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
• Axon Surged After Earnings and Is Still Down Over 50% From Highs
• The Event That Could Redefine Apple’s Summer Rally

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].